PKM and non-small cell lung carcinoma: In a previous study, we showed that cisplatin-resistant non-small cell lung cancer (NSCLC) cells transmitted drug resistance to sensitive cells by secreting PKM2-loaded exosomes in response to hypoxic stimulation (Wang et al., 2021).